Monoclonal Antibody Plus Interleukin-2 in Treating Patients With Leukemia or Lymphoma

NCT00002681 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

BIOLOGICAL: aldesleukin
BIOLOGICAL: daclizumab

Sponsor

Roger Williams Medical Center

Collaborators

[object Object]
[object Object]